WHC is still in active development. Read this to understand our approach.
depiction of DPYMFVXJLLWWEU-UHFFFAOYSA-N.svg
isomerdesign

Desflurane

Verificar en isomerdesign

pubchem

Desflurane

Verificar en pubchem

drugmap

Desflurane

Verificar en drugmap

wiki

Desflurane

Verificar en wiki

Data

InChI: InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H

Sinónimos: DESFLURANE [VANDF], 2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane,MFCD00236716, Desflurane (JAN/USP/INN),UNII-CRS35BZ94Q,57041-67-5,Desflurano [INN-Spanish], I653,Q419383,DB-053001,1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane,D00546,Suprane,DESFLURANE [MI],1351959-69-7,Desfluran-O, Desflurano [INN-Spanish],ETHANE, 2-(DIFLUOROMETHOXY)-1,1,1,2-TETRAFLUORO-, (+/-)-,EN300-7635854,1,2,2,2-Tetrafluoroethyl difluoromethyl ether, Desflurane [USAN:INN],Desfluranum,CHEBI:4445,Difluoromethyl1,2,2,2-tetrafluoroethylether,DESFLURANE [ORANGE BOOK],FT-0624525, R-e 236ea1,Desflurane (JAN/USP/INN), Suprane (TN),difluoromethyl 1,2,2,2-tetrafluoroethyl ether,DTXSID80866606,CHEMBL1200733, (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether,DESFLURANE [WHO-DD],2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane,SCHEMBL62917,Desfluranum [INN-Latin],Ethane,2-(difluoromethoxy)-1,1,1,2-tetrafluoro-,(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether,Desflurano,DESFLURANE [USP MONOGRAPH],DESFLURANE [USP-RS],DESFLURANE [USAN], I-653,DESFLURANE [INN],DB01189, 1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane, Desfluranum [INN-Latin], PC6781E,DESFLURANE [JAN], Suprane,Suprane (TN),GTPL7156,CRS35BZ94Q,Desflurane [USAN:USP:INN:BAN],DESFLURANE,C07519,Desflurane,(+/-)-2-difluoromethyl 1,2,2,2-tetrafluoroethyl ether,I-653,AKOS006228397, Difluoromethyl 1,2,2,2-tetrafluoroethyl ether,Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-, I 653,CHF2OCHFCF3, Desfluranum,Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-, (+-)-,I 653,DESFLURANE [MART.],DESFLURANE [EP MONOGRAPH],HSDB 8058


Estimated data

Solubilidad: -1.628 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 59.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.